Haemonetics Corp (NYSE:HAE)

83.01
Delayed Data
As of 3:59pm ET
 +0.44 / +0.53%
Today’s Change
48.67
Today|||52-Week Range
91.39
+5.54%
Year-to-Date

Stock Price Forecast

The 7 analysts offering 12-month price forecasts for Haemonetics Corp have a median target of 100.00, with a high estimate of 115.00 and a low estimate of 88.00. The median estimate represents a +20.47% increase from the last price of 83.01.

Analyst Recommendations

The current consensus among 8 polled investment analysts is to Buy stock in Haemonetics Corp. This rating has held steady since September, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$0.71
Sales
$287.6M
Reporting Date
May 09

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -16.25%
 
 
 
 
 
 
Growthannually 14.50%
 
 
 
 
 
 

Sales

Growthquarterly -5.81%
 
 
 
 
 
 
Growthannually 15.72%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.